Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model

Non-alcoholic steatohepatitis (NASH) can cause liver cirrhosis and hepatocellular carcinoma (HCC), with cases increasing worldwide. To reduce the incidence of liver cirrhosis and HCC, NASH is targeted for the development of treatments, along with viral hepatitis and alcoholic hepatitis. Lactoferrin...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Yoshinaga, Naiki-Ito, Aya, Xiaochen, Kuang, Komura, Masayuki, Kato, Hiroyuki, Nagayasu, Yuko, Inaguma, Shingo, Tsuda, Hiroyuki, Tomita, Mamoru, Matsuo, Yoichi, Takiguchi, Shuji, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746867/
https://www.ncbi.nlm.nih.gov/pubmed/35010924
http://dx.doi.org/10.3390/nu14010042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746867/
https://www.ncbi.nlm.nih.gov/pubmed/35010924
http://dx.doi.org/10.3390/nu14010042

Ejemplares similares